The Valley Desk

NCT03689244 · Interventional trial

A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Overall registry status Terminated

Phase 3

Conditions Chronic Thromboembolic Pulmonary Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov